(Reuters) -Indian drugmaker Torrent Pharma reported a 30.5% rise in its second-quarter profit on Friday, driven by strong domestic demand for its cardiovascular and anti-diabetic drugs.

The company reported consolidated net profit of 5.91 billion rupees ($67.24 million) for the quarter ended September 30.

Overall revenue rose 14.3% to 33.02 billion rupees.

For further earnings highlights, click here.

KEY CONTEXT

The Indian pharmaceutical market grew 7.3% in value in September, driven by strong sales in cardiovascular, anti-diabetic, and anti-infectives therapies, according to data from PharmaRack.

The demand boosted Torrent Pharma’s domestic revenue, which accounts for more than half of overall revenue, by 12% to 18.2 billion rupees.

To further boost sales, Torrent Pharma launched n

See Full Page